Acetazolamide
- Generic Name
- Acetazolamide
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C4H6N4O3S2
- CAS Number
- 59-66-5
- Unique Ingredient Identifier
- O3FX965V0I
- Background
One of the carbonic anhydrase inhibitors that is sometimes effective against absence seizures. It is sometimes useful also as an adjunct in the treatment of tonic-clonic, myoclonic, and atonic seizures, particularly in women whose seizures occur or are exacerbated at specific times in the menstrual cycle. However, its usefulness is transient often because of...
- Indication
For adjunctive treatment of: edema due to congestive heart failure; drug-induced edema; centrencephalic epilepsies; chronic simple (open-angle) glaucoma
- Associated Conditions
- Acute angle-closure glaucoma, Edema, Familial periodic paralysis, Generalized Tonic-Clonic Seizures, Metabolic Alkalosis, Open Angle Glaucoma (OAG), Other and unspecified effects of high altitude, Cystine renal calculi, Drug-induced edema, Nonuveitic secondary glaucoma, Salicylate intoxication
- Associated Therapies
- Urine alkalinization therapy
Impact of Acetazolamide in Reducing Referred Postoperative Pain
- First Posted Date
- 2020-07-14
- Last Posted Date
- 2022-09-23
- Lead Sponsor
- Medical College of Wisconsin
- Target Recruit Count
- 33
- Registration Number
- NCT04470843
- Locations
- 🇺🇸
Froedtert Memorial Lutheran Hospital, Milwaukee, Wisconsin, United States
Acetazolamide for the Prevention of Post Operative CSF Leak
- First Posted Date
- 2020-04-17
- Last Posted Date
- 2021-12-14
- Lead Sponsor
- University of Miami
- Registration Number
- NCT04351061
- Locations
- 🇺🇸
University of Miami, Miami, Florida, United States
Treatment of Chronic Mountain Sickness
- Conditions
- Interventions
- First Posted Date
- 2020-01-31
- Last Posted Date
- 2021-08-20
- Lead Sponsor
- Centre d'Expertise sur l'Altitude EXALT
- Target Recruit Count
- 60
- Registration Number
- NCT04251364
- Locations
- 🇫🇷
Association EXALT, UM Sport Pathologies, Hôpital Sud, Avenue Kimberley, Échirolles, France
Acetazolamide Add-On Therapy to OSA Surgery
- Conditions
- Interventions
- First Posted Date
- 2020-01-13
- Last Posted Date
- 2024-06-18
- Lead Sponsor
- University Hospital, Antwerp
- Target Recruit Count
- 26
- Registration Number
- NCT04227093
- Locations
- 🇧🇪
Antwerp University Hospital, Edegem, Antwerp, Belgium
Quantitative D-dimer Level and Anticoagulant Therapy in Idiopathic Intracranial Hypertension
- Conditions
- Interventions
- First Posted Date
- 2019-05-24
- Last Posted Date
- 2019-05-24
- Lead Sponsor
- Fayoum University
- Target Recruit Count
- 48
- Registration Number
- NCT03963336
- Locations
- 🇪🇬
Fayoum University Hospital, Fayoum, Egypt
Acetazolamide (AZ) for Management of Alkalosis in Bartter Syndrome
- Conditions
- Interventions
- First Posted Date
- 2019-02-20
- Last Posted Date
- 2019-02-20
- Lead Sponsor
- Tehran University of Medical Sciences
- Target Recruit Count
- 20
- Registration Number
- NCT03847571
- Locations
- 🇮🇷
Fateme Ghane Sharbaf, Mashhad, Iran, Islamic Republic of
🇮🇷Semnan University of Medical Sciences, Semnan, Iran, Islamic Republic of
🇮🇷Banafshe Dormansh, Tehran, Iran, Islamic Republic of
A Noninvasive Arterial Input Estimation Method for O-15 PET and Integrated PET/MR Scanning
- Conditions
- Interventions
- First Posted Date
- 2019-01-16
- Last Posted Date
- 2024-03-01
- Lead Sponsor
- University of Alabama at Birmingham
- Registration Number
- NCT03806751
- Locations
- 🇺🇸
UAB Advanced Imaging Facility, Birmingham, Alabama, United States
Acetazolamide for Treating NPH in Shunt-candidates Patients
- First Posted Date
- 2018-12-19
- Last Posted Date
- 2018-12-19
- Lead Sponsor
- Rabin Medical Center
- Target Recruit Count
- 15
- Registration Number
- NCT03779594
- Locations
- 🇮🇱
Rabin Medical Center, Petah Tikva, Israel
Acetazolamide in Patients With Acute Heart Failure
- First Posted Date
- 2018-10-25
- Last Posted Date
- 2018-10-30
- Lead Sponsor
- University of Sao Paulo General Hospital
- Target Recruit Count
- 90
- Registration Number
- NCT03720288
- Locations
- 🇧🇷
Instituto do Coração - HMFMUSP, São Paulo, Brazil
Cerebrovascular Reserve and White Matter Disease in Patients with Chronic Anemia
- Conditions
- Interventions
- First Posted Date
- 2018-10-23
- Last Posted Date
- 2024-10-30
- Lead Sponsor
- Children's Hospital Los Angeles
- Target Recruit Count
- 165
- Registration Number
- NCT03715972
- Locations
- 🇺🇸
CHLA, Los Angeles, California, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.